U.S. approval of cheap, generic HIV prevention shot may boost global rollout

T1Covered by 1 source · first reported by Nature / Science / Nature Biotechnology at 02 Nov, 05:25 UTC

Indian company pledges to sell injectable lenacapavir in low- and middle-income countries for only $40 a year

india

Sources

• T1U.S. approval of cheap, generic HIV prevention shot may boost global rolloutNature / Science / Nature Biotechnology02 Nov, 05:25